Synfacts, Inhaltsverzeichnis Synfacts 2024; 20(04): 0421DOI: 10.1055/s-0043-1763684 Innovative Drug Discovery and Development Discovery of Indazole-Based Selective IRAK4 Inhibitors Rezensent(en): Antonia F. Stepan (Roche) , Seong Heon Kim (Hyundai Pharm) Artikel empfehlen Abstract Artikel einzeln kaufen Key words Key wordsIRAK4 - indazoles - inflammatory diseases - BAY1830839 - BAY1834845 - zabedosertib - clinical candidates Volltext